Healthcare Bearish Stocks: Mediwound (NASDAQ:MDWD), Five Star Quality Care (NYSE:FVE), Ventrus Biosciences (NASDAQ:VTUS), Tonix Pharmaceuticals Holding (NASDAQ:TNXP)

Israeli-based MediWound Ltd (NASDAQ:MDWD) has developed a treatment to remove dead skin from burn wounds, and it has been approved by the European Medicines Agency. Mediwound Ltd (NASDAQ:MDWD) stock performance was -6.88% in last session and finished the day at $14.48. Traded volume was 485.2K shares in the last session and the average volume of the stock remained 1.40million shares. Five Star Quality Care, Inc. … Continue reading Healthcare Bearish Stocks: Mediwound (NASDAQ:MDWD), Five Star Quality Care (NYSE:FVE), Ventrus Biosciences (NASDAQ:VTUS), Tonix Pharmaceuticals Holding (NASDAQ:TNXP)

Healthcare Bullish Stocks: Momenta Pharmaceuticals (NASDAQ:MNTA), Orthofix International (NASDAQ:OFIX), Oxygen Biotherapeutics (NASDAQ:OXBT), Curis (NASDAQ:CRIS)

The U.S. Supreme Court on Monday for the second time did not announce whether it would hear an appeal by Teva Pharmaceuticals in a patent fight with generic competitors over its top-selling multiple sclerosis drug Copaxone. The nine justices are considering whether to review a July 2013 ruling by the U.S. Court of Appeals in favor of two cheaper generic forms of Copaxone by Novartis … Continue reading Healthcare Bullish Stocks: Momenta Pharmaceuticals (NASDAQ:MNTA), Orthofix International (NASDAQ:OFIX), Oxygen Biotherapeutics (NASDAQ:OXBT), Curis (NASDAQ:CRIS)

Tech Movers: Nokia Corporation (ADR) (NYSE:NOK), Groupon Inc (NASDAQ:GRPN), Ford Motor Company (NYSE:F), General Motors Company (NYSE:GM)

Nokia Corporation (ADR) (NYSE:NOK) calls and puts traded in near parity yesterday, as about 45,000 total contracts were on the tape by the closing bell. Accounting for more than one-quarter of the action was the mobile concern’s May 6 put, which saw north of 12,000 contracts change hands throughout the session. Nokia Corporation (ADR) (NYSE:NOK) stock performance was -0.55% in last session and finished the … Continue reading Tech Movers: Nokia Corporation (ADR) (NYSE:NOK), Groupon Inc (NASDAQ:GRPN), Ford Motor Company (NYSE:F), General Motors Company (NYSE:GM)

Biotech New Lows: Galmed Pharmaceuticals (NASDAQ:GLMD), Recro Pharma (NASDAQ:REPH), BioTime (NYSEMKT:BTX), Onconova Therapeutics (NASDAQ:ONTX)

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) announced the closing of its initial public offering of 3,263,010 ordinary shares at a public offering price of $13.50 per share, which included 425,610 ordinary shares issued upon the exercise in full of the underwriters’ option to purchase additional ordinary shares to cover over-allotments. Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) stock performance was -1.58% in last session and finished the day at $10.93. … Continue reading Biotech New Lows: Galmed Pharmaceuticals (NASDAQ:GLMD), Recro Pharma (NASDAQ:REPH), BioTime (NYSEMKT:BTX), Onconova Therapeutics (NASDAQ:ONTX)

Biotech Losers: China Biologic Products (NASDAQ:CBPO), Heat Biologics (NASDAQ:HTBX), Recro Pharma Inc (NASDAQ:REPH), Egalet Corp (NASDAQ:EGLT)

China Biologic Products, Inc. (NASDAQ:CBPO), a leading fully integrated plasma-based biopharmaceutical company in China , today announced its financial results for the fourth quarter and fiscal year 2013. China Biologic Products Inc (NASDAQ:CBPO) stock performance was -6.25% in last session and finished the day at $32.85. Traded volume was 32,311.00million shares in the last session and the average volume of the stock remained 21.68K shares. … Continue reading Biotech Losers: China Biologic Products (NASDAQ:CBPO), Heat Biologics (NASDAQ:HTBX), Recro Pharma Inc (NASDAQ:REPH), Egalet Corp (NASDAQ:EGLT)

Biotech Gainers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Northwest Biotherapeutics (NASDAQ:NWBO), Peregrine Pharmaceuticals (NASDAQ:PPHM), Dyax (NASDAQ:DYAX)

Trade-Ideas LLC identified Inovio Pharmaceuticals Inc (NYSEMKT:INO) as a “barbarian at the gate” (strong stocks crossing above resistance with today’s range greater than 200%) candidate. Inovio Pharmaceuticals, Inc. (NYSEMKT:INO), together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases. Currently there are 3 analysts that rate Inovio Pharmaceuticals Inc (NYSEMKT:INO) a buy, no … Continue reading Biotech Gainers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Northwest Biotherapeutics (NASDAQ:NWBO), Peregrine Pharmaceuticals (NASDAQ:PPHM), Dyax (NASDAQ:DYAX)